241 related articles for article (PubMed ID: 22199357)
1. Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.
Meng X; Zhu D; Yang S; Wang X; Xiong Z; Zhang Y; Brachova P; Leslie KK
J Biol Chem; 2012 Feb; 287(7):4485-91. PubMed ID: 22199357
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of MTDH sensitizes endometrial cancer cells to cell death induction by death receptor ligand TRAIL and HDAC inhibitor LBH589 co-treatment.
Meng X; Brachova P; Yang S; Xiong Z; Zhang Y; Thiel KW; Leslie KK
PLoS One; 2011; 6(6):e20920. PubMed ID: 21687633
[TBL] [Abstract][Full Text] [Related]
3. Metadherin contributes to the pathogenesis of diffuse large B-cell lymphoma.
Ge X; Lv X; Feng L; Liu X; Gao J; Chen N; Wang X
PLoS One; 2012; 7(6):e39449. PubMed ID: 22768080
[TBL] [Abstract][Full Text] [Related]
4. Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-κB pathway.
Zhang J; Zhang Y; Liu S; Zhang Q; Wang Y; Tong L; Chen X; Ji Y; Shang Q; Xu B; Chu M; Wei L
Tumour Biol; 2013 Aug; 34(4):2433-40. PubMed ID: 23595222
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancer.
Li JW; Huang CZ; Li JH; Yuan JH; Chen QH; Zhang WF; Xu ZS; Liu YP; Li Y; Zhan MX; Lu LG
Oncol Rep; 2018 Oct; 40(4):2215-2223. PubMed ID: 30015962
[TBL] [Abstract][Full Text] [Related]
6. Genetic ablation of metadherin inhibits autochthonous prostate cancer progression and metastasis.
Wan L; Hu G; Wei Y; Yuan M; Bronson RT; Yang Q; Siddiqui J; Pienta KJ; Kang Y
Cancer Res; 2014 Sep; 74(18):5336-47. PubMed ID: 25074613
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
8. MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer.
Hu G; Chong RA; Yang Q; Wei Y; Blanco MA; Li F; Reiss M; Au JL; Haffty BG; Kang Y
Cancer Cell; 2009 Jan; 15(1):9-20. PubMed ID: 19111877
[TBL] [Abstract][Full Text] [Related]
9. Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.
Yang L; Tian Y; Leong WS; Song H; Yang W; Wang M; Wang X; Kong J; Shan B; Song Z
Breast Cancer Res; 2018 Sep; 20(1):113. PubMed ID: 30227879
[TBL] [Abstract][Full Text] [Related]
10. Autophagy Facilitates Metadherin-Induced Chemotherapy Resistance Through the AMPK/ATG5 Pathway in Gastric Cancer.
Pei G; Luo M; Ni X; Wu J; Wang S; Ma Y; Yu J
Cell Physiol Biochem; 2018; 46(2):847-859. PubMed ID: 29635244
[TBL] [Abstract][Full Text] [Related]
11. CPEB1 regulates the expression of MTDH/AEG-1 and glioblastoma cell migration.
Kochanek DM; Wells DG
Mol Cancer Res; 2013 Feb; 11(2):149-60. PubMed ID: 23360795
[TBL] [Abstract][Full Text] [Related]
12. Role of metadherin in estrogen-regulated gene expression.
Li Y; Gonzalez Bosquet J; Yang S; Thiel KW; Zhang Y; Liu H; Leslie KK; Meng X
Int J Mol Med; 2017 Aug; 40(2):303-310. PubMed ID: 28627585
[TBL] [Abstract][Full Text] [Related]
13. Structural insights into the tumor-promoting function of the MTDH-SND1 complex.
Guo F; Wan L; Zheng A; Stanevich V; Wei Y; Satyshur KA; Shen M; Lee W; Kang Y; Xing Y
Cell Rep; 2014 Sep; 8(6):1704-1713. PubMed ID: 25242325
[TBL] [Abstract][Full Text] [Related]
14. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
[TBL] [Abstract][Full Text] [Related]
15. Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer.
Haug S; Schnerch D; Halbach S; Mastroianni J; Dumit VI; Follo M; Hasenburg A; Köhler M; Dierbach H; Herzog S; Proske A; Werner M; Dengjel J; Brummer T; Laßmann S; Wäsch R; Zeiser R
Int J Cancer; 2015 May; 136(10):2328-40. PubMed ID: 25346496
[TBL] [Abstract][Full Text] [Related]
16. MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment.
Gu C; Feng L; Peng H; Yang H; Feng Z; Yang Y
Oncotarget; 2016 Jan; 7(4):4559-69. PubMed ID: 26683226
[TBL] [Abstract][Full Text] [Related]
17. Metadherin (AEG-1/MTDH/LYRIC) expression: Significance in malignancy and crucial role in colorectal cancer.
Abdel Ghafar MT; Soliman NA
Adv Clin Chem; 2022; 106():235-280. PubMed ID: 35152973
[TBL] [Abstract][Full Text] [Related]
18.
Wang SS; Zhai GQ; Chen G; Huang ZG; Zhang Y; Zhang LJ; Dang YW; Li SH; Yan HB
Cancer Biother Radiopharm; 2023 Nov; 38(9):650-662. PubMed ID: 35704039
[No Abstract] [Full Text] [Related]
19. The multifaceted role of MTDH/AEG-1 in cancer progression.
Hu G; Wei Y; Kang Y
Clin Cancer Res; 2009 Sep; 15(18):5615-20. PubMed ID: 19723648
[TBL] [Abstract][Full Text] [Related]
20. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer.
Hui AB; Bruce JP; Alajez NM; Shi W; Yue S; Perez-Ordonez B; Xu W; O'Sullivan B; Waldron J; Cummings B; Gullane P; Siu L; Liu FF
Clin Cancer Res; 2011 Dec; 17(24):7539-50. PubMed ID: 22031094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
